Industry Challenges FDA's User Fee Markup
This article was originally published in The Gray Sheet
During the first round of user fee negotiations, industry questioned FDA's estimated cost of $750 million needed to continue the device user fee program between 2018 and 2022. Lobby groups for the device industry continue to emphasize user fees should supplement congressional appropriations to pay for FDA's review of devices.
Register for our free email digests: